CH3 BioSystems

Methylation Biology Leader

CH3 BioSystems is a biotechnology company based on an entirely new patent-protected chemical technology designed to identify and commercialize drug and diagnostic candidates. The company offers unique cell lines for research and drug discovery. They manufacture novel molecular tools that facilitate biomedical research. Their goal is a better understanding of cancer and autoimmune, neurodevelopmental, viral and cardiovascular diseases that affect millions of people around the world.

 

Product Range:

- Antibodies
- Cell Lines
- Enzymes
- Peptides
- Expression Vector
- shRNA Vector
- Luciferase Reporters